Opposing functions of IKKβ during acute and chronic intestinal inflammation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 39, 2008, Pages 15058-15063

  Eckmann, Lars ^a   Nebelsiek, Tim ^c   Fingerle, Alexander A ^c   Dann, Sara M ^a   Mages, Jörg ^d   Lang, Roland ^d   Robine, Sylvie ^e   Kagnoff, Martin F ^a   Schmid, Roland M ^c   Karin, Michael ^b   Arkan, Melek C ^c   Greten, Florian R ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e CNRS   (France)

Author keywords

Apoptosis; Colitis; Heat shock protein 70; NF B; STAT3

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; DEXTRAN SULFATE; I KAPPA B KINASE; INTERLEUKIN 1; STAT3 PROTEIN; STAT3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL SURVIVAL; COLITIS; CONTROLLED STUDY; ENTERITIS; INTESTINE ULCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ACUTE DISEASE; ANIMAL; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; DISEASE MODEL; DRUG ANTAGONISM; GENE EXPRESSION; GENETICS; INTESTINE MUCOSA; METABOLISM; MOUSE MUTANT; ULCERATIVE COLITIS;

MURINAE; MUS;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; COLITIS, ULCERATIVE; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; I-KAPPA B KINASE; INTERLEUKIN-1; INTESTINAL MUCOSA; MICE; MICE, MUTANT STRAINS; NF-KAPPA B; STAT3 TRANSCRIPTION FACTOR;

EID: 54449091097     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0808216105     Document Type: Article

References (37)

1. Sartor RB (2006) Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3:390-407.
2. Hayden MS, Ghosh S (2004) Signaling to NF-κB. Genes Dev 18:2195-2224.
3. Viemann D, et al. (2004) Transcriptional profiling of IKK2/NF-κB- and p38 MAP kinase-dependent gene expression in TNF-α-stimulated primary human endothelial cells. Blood 103:3365-3373.
4. Karin M, Lin A (2002) NF-κB at the crossroads of life and death. Nat Immunol 3:221-227.
5. Hacker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006, re13.
6. Karin M, Yamamoto Y, Wang QM (2004) The IKK NF-κB system: A treasure trove for drug development. Nat Rev Drug Discov 3:17-26.
7. Broide DH, et al. (2005) Allergen-induced peribronchial fibrosis and mucus production mediated by IκB kinase β-dependent genes in airway epithelium. Proc Natl Acad Sci USA 102:17723-17728.
8. Ruocco MG, et al. (2005) IκB kinase (IKK)β but not IKKα is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J Exp Med 201:1677-1687.
9. McIntyre KW, et al. (2003) A highly selective inhibitor of IκB kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum 48:2652-2659.
10. Lawrance IC, et al. (2003) A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-κB. Gastroenterology 125:1750-1761.
11. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med 2:998-1004.
12. MacMaster JF, et al. (2003) An inhibitor of IκB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice. Inflamm Res 52:508-511.
13. Greten FR, et al. (2004) IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118:285-296.
14. Nenci A, et al. (2007) Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446:557-561.
15. Greten FR, et al. (2007) NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of IKKβ. Cell 130:918-931.
16. Strnad J, Burke JR (2007) IκB kinase inhibitors for treating autoimmune and inflammatory disorders: Potential and challenges. Trends Pharmacol Sci 28:142-148.
17. Egan LJ, et al. (2004) IκB-kinaseβ-dependent NF-κB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci USA 101:2452-2457.
18. Chen LW, et al. (2003) The two faces of IKK and NF-κB inhibition: Prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat Med 9:575-581.
19. Egan LJ, et al. (2003) Nuclear factor-κB activation promotes restitution of wounded intestinal epithelial monolayers. Am J Physiol 285:C1028-C1035.
20. Nagashima K, et al. (2006) Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKβ. Blood 107:4266-4273.
21. Li X, et al. (2002) IKKα, IKKβ, and NEMO/IKKγ are each required for the NF-κB-mediated inflammatory response program. J Biol Chem 277:45129-45140.
22. Wu F, Chakravarti S (2007) Differential expression of inflammatory and fibrogenic genes and their regulation by NF-κB inhibition in a mouse model of chronic colitis. J Immunol 179:6988-7000.
23. Tanaka K, et al. (2007) Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis. J Biol Chem 282:23240-23252.
24. Stephanou A, Latchman DS (1999) Transcriptional regulation of the heat shock protein genes by STAT family transcription factors. Gene Expression 7:311-319.
25. el Marjou F, et al. (2004) Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39:186-193.
26. Li ZW, et al. (2003) IKKβ is required for peripheral B cell survival and proliferation. J Immunol 170:4630-4637.
27. Kuhn R, et al. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263-274.
28. Fort MM, et al. (2005) A synthetic TLR4 antagonist has antiinflammatory effects in two murine models of inflammatory bowel disease. J Immunol 174:6416-6423.
29. Peterson RL, et al. (1998) Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab Invest 78:1503-1512.
30. Qualls JE, Kaplan AM, van Rooijen N, Cohen DA (2006) Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukocyte Biol 80:802-815.
31. Sikora A, Grzesiuk E (2007) Heat shock response in gastrointestinal tract. J Physiol Pharmacol 58(Suppl 3):43- 62.
32. Laubitz D, et al. (2006) Gut myoelectrical activity induces heat shock response in Escherichia coli and Caco-2 cells. Exp Physiol 91:867-875.
33. -/-) mice and intestinal inflammation. Am J Physiol 278:G829-G833.
34. Karin M, Greten FR (2005) NF-κB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759.
35. Madison BB, et al. (2002) Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J Biol Chem 277:33275-33283.
36. Katakura K, et al. (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115:695-702.
37. Hammer M, et al. (2006) Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J Exp Med 203:15-20.